Platelets from pulmonary hypertension patients show increased mitochondrial reserve capacity.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  JCI Insight

• Publication date

  2017-03-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1172/jci.insight.91415PMID 28289721PMCID PMC5333965
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension

  2016cited by this paper
• Mapping the Human Platelet Lipidome Reveals Cytosolic Phospholipase A2 as a Regulator of Mitochondrial Bioenergetics during Activation

  2016cited by this paper
• The Role of Bone Marrow-derived Cells in Pulmonary Arterial Hypertension. What Lies Beneath?

  2016cited by this paper
• Platelets from Asthmatic Individuals Show Less Reliance on Glycolysis

  2015cited by this paper
• Severe pulmonary hypertension is associated with altered right ventricle metabolic substrate uptake.

  2015cited by this paper
• Mitochondrial complex II is a source of the reserve respiratory capacity that is regulated by metabolic sensors and promotes cell survival

  2015cited by this paper
• AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress.

  2015cited by this paper
• Complex I dysfunction underlies the glycolytic switch in pulmonary hypertensive smooth muscle cells

  2015cited by this paper
• Mitochondria: roles in pulmonary hypertension.

  2014cited by this paper
• Molecular Mechanisms of Pulmonary Arterial Remodeling

  2014cited by this paper
• Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activation.

  2014cited by this paper
• The Metabolic Theory of Pulmonary Arterial Hypertension

  2014cited by this paper
• FDG PET Imaging for Identifying Pulmonary Hypertension and Right Heart Failure

  2014cited by this paper
• Pulmonary arterial hypertension: the clinical syndrome.

  2014cited by this paper
• Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension

  2014cited by this paper
• Pathology of pulmonary hypertension.

  2013cited by this paper
• Metabolic Gene Remodeling and Mitochondrial Dysfunction in Failing Right Ventricular Hypertrophy Secondary to Pulmonary Arterial Hypertension

  2013cited by this paper
• Bone Marrow–Derived Vascular Modulatory Cells in Pulmonary Arterial Hypertension

  2013cited by this paper
• A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension

  2013cited by this paper
• The Fifth World Symposium on Pulmonary Hypertension.

  2013cited by this paper
• A bioenergetic profile of non-transformed fibroblasts uncovers a link between death-resistance and enhanced spare respiratory capacity.

  2013cited by this paper
• FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate

  2012cited by this paper
• Dynamin-Related Protein 1–Mediated Mitochondrial Mitotic Fission Permits Hyperproliferation of Vascular Smooth Muscle Cells and Offers a Novel Therapeutic Target in Pulmonary Hypertension

  2012cited by this paper
• Platelets in Pulmonary Hypertension: a Causative Role or a Simple Association?

  2012cited by this paper
• Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension.

  2012cited by this paper
• Mast cell inhibition improves pulmonary vascular remodeling in pulmonary hypertension.

  2012cited by this paper
• Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle’s cycle

  2011cited by this paper
• Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

  2011cited by this paper
• C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension.

  2011cited by this paper
• The role of the right ventricle in pulmonary arterial hypertension

  2011cited by this paper
• PET Imaging May Provide a Novel Biomarker and Understanding of Right Ventricular Dysfunction in Patients With Idiopathic Pulmonary Arterial Hypertension

  2011cited by this paper
• Platelet Mitochondrial Dysfunction is Evident in Type 2 Diabetes in Association with Modifications of Mitochondrial Anti-Oxidant Stress Proteins

  2011cited by this paper
• Establishing a relationship between prolactin and altered fatty acid β-Oxidation via carnitine palmitoyl transferase 1 in breast cancer cells

  2011cited by this paper
• The role of mitochondria in pulmonary vascular remodeling

  2010cited by this paper
• Fatty Acid Oxidation and Malonyl-CoA Decarboxylase in the Vascular Remodeling of Pulmonary Hypertension

  2010cited by this paper
• Temporal increase of platelet mitochondrial respiration is negatively associated with clinical outcome in patients with sepsis

  2010cited by this paper
• The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension.

  2009cited by this paper
• Importance of the bioenergetic reserve capacity in response to cardiomyocyte stress induced by 4-hydroxynonenal.

  2009cited by this paper
• The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle

  2009cited by this paper
• Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor.

  2008cited by this paper
• Alterations of cellular bioenergetics in pulmonary artery endothelial cells

  2007cited by this paper
• Pathology of pulmonary hypertension.

  2007cited by this paper
• Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species.

  2007cited by this paper
• Spare Respiratory Capacity Rather Than Oxidative Stress Regulates Glutamate Excitotoxicity after Partial Respiratory Inhibition of Mitochondrial Complex I with Rotenone

  2007cited by this paper
• Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer

  2007cited by this paper
• An Abnormal Mitochondrial–Hypoxia Inducible Factor-1&agr;–Kv Channel Pathway Disrupts Oxygen Sensing and Triggers Pulmonary Arterial Hypertension in Fawn Hooded Rats: Similarities to Human Pulmonary Arterial Hypertension

  2006influential reference
• Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage.

  2006cited by this paper
• Thrombotic arteriopathy and anticoagulation in pulmonary hypertension.

  2006cited by this paper
• Dichloroacetate Prevents and Reverses Pulmonary Hypertension by Inducing Pulmonary Artery Smooth Muscle Cell Apoptosis

  2004cited by this paper
• Pathobiology of pulmonary hypertension. The role of platelets and thrombosis.

  2001cited by this paper
• Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension.

  2000cited by this paper
• Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years.

  1998cited by this paper
• Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

  1991cited by this paper
• Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.

  1984cited by this paper
• Prostaglandins and platelets.

  1980cited by this paper
• Prostaglandins and platelets.

  1968cited by this paper

• Acute Severe Hypoxia Decreases Mitochondrial Chain Complex II Respiration in Human Peripheral Blood Mononuclear Cells

  2025cites this paper
• Platelets from older adults exhibit differences in mitochondrial function associated with impaired glucose metabolism

  2025cites this paper
• Chemically Defined, Efficient Megakaryocyte Production from Human Pluripotent Stem Cells

  2025cites this paper
• Are Hippocampal Hypoperfusion and ATP Depletion Prime Movers in the Genesis of Alzheimer’s Disease? A Review of Recent Pertinent Observations from Molecular Biology

  2025cites this paper
• Understanding the Role of Oxidative Stress in Platelet Alterations and Thrombosis Risk among Frail Older Adults

  2024cites this paper
• Lung EC-SOD Overexpression Prevents Hypoxia-Induced Platelet Activation and Lung Platelet Accumulation

  2024cites this paper
• Aberrant mitochondrial DNA synthesis in macrophages exacerbates inflammation and atherosclerosis

  2024cites this paper
• Extrapulmonary manifestations of pulmonary arterial hypertension

  2024cites this paper
• Myoglobin Inhibits Breast Cancer Cell Fatty Acid Oxidation and Migration via Heme-dependent Oxidant Production and Not Fatty Acid Binding

  2024cites this paper
• Platelet bioenergetic profiling uncovers a metabolic pattern of high dependency on mitochondrial fatty acid oxidation in type 2 diabetic patients who developed in-stent restenosis

  2024cites this paper
• Platelet Bioenergetics and Associations With Delirium and Coma in Patients With Sepsis

  2024cites this paper
• Fatty acid oxidation fuels natural killer cell responses against infection and cancer

  2024cites this paper
• Alterations in Mitochondrial Function in Pulmonary Vascular Diseases

  2024cites this paper
• Myoglobin Inhibits Breast Cancer Cell Fatty Acid Oxidation and Migration via Heme-dependent Oxidant Production and Not Fatty Acid Binding.

  2024cites this paper
• Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?

  2023cites this paper
• Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms

  2023cites this paper
• Metabolic targeting of platelets to combat thrombosis: dawn of a new paradigm?

  2023cites this paper
• Serum factors mediate changes in mitochondrial bioenergetics associated with diet and exercise interventions

  2023cites this paper
• Elevated LDL-C, high blood pressure, and low peak V˙ O2 associate with platelet mitochondria function in children—The Arkansas Active Kids Study

  2023cites this paper
• Mitochondrial Respiration in Peripheral Blood Mononuclear Cells Negatively Correlates with Disease Severity in Pulmonary Arterial Hypertension

  2022cites this paper
• Metabolism, Mitochondrial Dysfunction, and Redox Homeostasis in Pulmonary Hypertension

  2022cites this paper
• Vascular pathobiology of pulmonary hypertension.

  2022cites this paper
• Inhibition of mitochondrial complex I leading to NAD+/NADH imbalance in type 2 diabetic patients who developed late stent thrombosis: Evidence from an integrative analysis of platelet bioenergetics and metabolomics

  2022cites this paper
• Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease

  2022cites this paper
• Platelets, extracellular vesicles and coagulation in pulmonary arterial hypertension

  2021cites this paper
• Assessment of platelets in patients with pulmonary hypertension

  2021cites this paper
• Disease Specific Platelet Signaling Defects in Idiopathic Pulmonary Arterial Hypertension.

  2021cites this paper
• Human Platelet Mitochondrial Function Reflects Systemic Mitochondrial Alterations: A Protocol for Application in Field Studies

  2021cites this paper
• Mitochondrial Respiration Defects in Single-Ventricle Congenital Heart Disease

  2021cites this paper
• New Insights into the Implication of Mitochondrial Dysfunction in Tissue, Peripheral Blood Mononuclear Cells, and Platelets during Lung Diseases

  2020cites this paper
• Platelet Glycolytic Metabolism Correlates with Hemodynamic Severity in Pulmonary Arterial Hypertension.

  2020cites this paper
• Mitochondrial spare respiratory capacity: Mechanisms, regulation, and significance in non‐transformed and cancer cells

  2020cites this paper
• Beyond Thrombosis: the Role of Platelets in Pulmonary Hypertension

  2020cites this paper
• Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement

  2020cites this paper
• Blood-based bioenergetics: An emerging translational and clinical tool.

  2019cites this paper
• The Biological Bases of Group 2 Pulmonary Hypertension

  2019cites this paper
• Bioenergetic Differences in the Airway Epithelium of Lean Versus Obese Asthmatics Are Driven by Nitric Oxide and Reflected in Circulating Platelets

  2019cites this paper
• Bioenergetics and translational metabolism: implications for genetics, physiology and precision medicine

  2019cites this paper
• Alterations in platelet bioenergetics in Group 2 PH-HFpEF patients

  2019cites this paper
• Alterations of complex IV in the tissues of a septic mouse model.

  2019cites this paper
• Platelet bioenergetics correlate with muscle energetics and are altered in older adults.

  2019influential citation
• Focus on Early Events: Pathogenesis of Pulmonary Arterial Hypertension Development

  2019cites this paper
• The redox physiology of red blood cells and platelets: implications for their interactions and potential use as systemic biomarkers

  2019cites this paper
• Assessment of platelet respiration as emerging biomarker of disease.

  2019cites this paper
• Metabolic syndrome, neurohumoral modulation, and pulmonary arterial hypertension

  2019cites this paper
• Platelet lipidome: Dismantling the “Trojan horse” in the bloodstream

  2019cites this paper
• Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains

  2018cites this paper
• Title : AMPK-ACC signaling modulates platelet phospholipids content and potentiates platelet function and thrombus formation Short title : AMPK-ACC signaling influences thrombus formation

  2018cites this paper
• Update in Pulmonary Vascular Disease 2016 and 2017

  2018cites this paper
• Moving mitochondria – Breathing new signaling into asthmatic airways

  2018cites this paper
• CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension

  2018cites this paper
• Pulmonary arterial hypertension and the potential roles of metallothioneins: A focused review

  2018cites this paper
• Rapid kinetics of changes in oxygen consumption rate in thrombin-stimulated platelets measured by high-resolution respirometry

  2018cites this paper
• AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation.

  2018cites this paper
• Multiomic profiling reveals metabolic alterations mediating Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative aberrant platelet activity and inflammation in myeloproliferative neoplasms neoplasms

  year unknowncites this paper